State Street’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$340M Sell
1,314,434
-27,869
-2% -$7.42M 0.01% 696
2025
Q4
$331M Sell
1,342,303
-53,664
-4% -$11.3M 0.01% 712
2025
Q3
$246M Buy
1,395,967
+40,621
+3% +$6.08M 0.01% 832
2025
Q2
$186M Buy
1,355,346
+128,639
+10% +$18.9M 0.01% 960
2025
Q1
$221M Sell
1,226,707
-52,268
-4% -$8.79M 0.01% 837
2024
Q4
$200M Sell
1,278,975
-173,836
-12% -$30.8M 0.01% 940
2024
Q3
$264M Buy
1,452,811
+119,936
+9% +$23.1M 0.01% 756
2024
Q2
$245M Buy
1,332,875
+388,328
+41% +$65.2M 0.01% 755
2024
Q1
$168M Sell
944,547
-292,950
-24% -$40.7M 0.01% 971
2023
Q4
$154M Buy
1,237,497
+205,670
+20% +$22.8M 0.01% 1012
2023
Q3
$120M Buy
1,031,827
+128,136
+14% +$15.6M 0.01% 1065
2023
Q2
$106M Sell
903,691
-122,704
-12% -$12.5M 0.01% 1177
2023
Q1
$82.2M Sell
1,026,395
-12,588
-1% -$989K ﹤0.01% 1317
2022
Q4
$82.3M Buy
1,038,983
+44,839
+5% +$3.33M ﹤0.01% 1300
2022
Q3
$69.3M Sell
994,144
-41,897
-4% -$3.03M ﹤0.01% 1367
2022
Q2
$68M Sell
1,036,041
-32,615
-3% -$2.03M ﹤0.01% 1431
2022
Q1
$71.1M Buy
1,068,656
+366,855
+52% +$22.9M ﹤0.01% 1534
2021
Q4
$49.1M Sell
701,801
-35,252
-5% -$2.05M ﹤0.01% 1812
2021
Q3
$38.5M Buy
737,053
+24,056
+3% +$1.42M ﹤0.01% 1997
2021
Q2
$48.5M Buy
712,997
+54,039
+8% +$3.77M ﹤0.01% 1869
2021
Q1
$50.8M Buy
658,958
+98,708
+18% +$7.18M ﹤0.01% 1737
2020
Q4
$33.6M Sell
560,250
-32,086
-5% -$1.6M ﹤0.01% 1903
2020
Q3
$25.5M Sell
592,336
-102,489
-15% -$4.45M ﹤0.01% 1894
2020
Q2
$28.8M Buy
694,825
+227,432
+49% +$10.9M ﹤0.01% 1823
2020
Q1
$20.2M Buy
467,393
+11,168
+2% +$584K ﹤0.01% 1832
2019
Q4
$25.3M Sell
456,225
-10,219
-2% -$501K ﹤0.01% 1978
2019
Q3
$16.2M Buy
466,444
+308,298
+195% +$13.8M ﹤0.01% 2193
2019
Q2
$6.37M Buy
158,146
+151,143
+2,158% +$4.94M ﹤0.01% 2703
2019
Q1
$230K Buy
+7,003
New +$165K ﹤0.01% 3555

Other funds holding KRYS